These findings were noted both in the presence and absence of continuous positive airway pressure (CPAP) therapy [86,87,88,89]
Prior Presentation: This work was presented in part at the 2025 International Society for Pharmacoepidemiology (ISPE) Annual Meeting held 2226 August in Washington, DC, USA
Government support programs: The Pharmaceutical Benefits Advisory Committee (PBAC) estimates that subsidising semaglutide for obesity would cost over $1 billion annually over a six-year period
Pancreatitis Acute pancreatitis has occurred in patients treated with GLP-1 agonists, including tirzepatide
Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial
Used responsibly under proper care, peptides can be a remarkable addition to a wellness plan